EDGAR Filing Documents for 0001564590-17-005091

Form 8-K - Current report:

SEC Accession No. 0001564590-17-005091

Filing Date

2017-03-23

Accepted

2017-03-23 08:00:16

Documents

Period of Report

2017-03-23

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	agle-8k_20170323.htm	8-K	35701
2	EX-99.1	agle-ex991_23.htm	EX-99.1	6809
3	GRAPHIC	gip14w3c5m1k000001.jpg	GRAPHIC	972990
	Complete submission text file	0001564590-17-005091.txt		1383943

Mailing Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746

Business Address 901 S. MOPAC EXPRESSWAY, STE. 250 BARTON OAKS PLAZA ONE AUSTIN TX 78746 (512) 942-2935

Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)